ARTICLES BY THIS AUTHOR
- 5/12/2010
First IL-6 receptor inhibitor for rheumatoid arthritis
Hoffmann-La Roche will soon be introducing Actemra (tocilizumab), the first interleukin-6 (IL-6) receptor inhibitor to be approved for the treatment of rheumatoid arthritis (RA). - 5/12/2010
NPs making an impact
- 5/11/2010
New pharmaceutical waste management tool